Pfizer and BioNTech Push Hard on Omicron-Specific Vaccine While Fending Off Lawsuits

While there’s no doubt about the success of the Pfizer and BioNTech COVID-19 vaccines, with that kind of success comes significant scrutiny and legal action. While the two companies push to develop and test COVID-19 vaccines specific to Omicron variants, they are also fending off lawsuits over their technology. Continue reading for more details.